Terence Flynn
Stock Analyst at Morgan Stanley
(4.73)
# 729
Out of 5,125 analysts
1126
Total ratings
58.9%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Terence Flynn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech | Maintained: Buy | $48 → $43 | $20.41 | +110.68% | 9 | Nov 11, 2026 | |
| BNTX BioNTech SE | Rated: Buy | $106 | $87.21 | +21.55% | 100 | Nov 9, 2026 | |
| MRNA Moderna | Rated: Hold | $95 | $250.83 | -62.13% | 39 | Nov 9, 2026 | |
| ARVN Arvinas | Rated: Hold | $10 | $6.92 | +44.51% | 26 | Nov 6, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Hold | $15 | $11.17 | +34.29% | 20 | Nov 6, 2026 | |
| RCUS Arcus Biosciences | Rated: Hold | $23 | $18.67 | +23.19% | 18 | Nov 6, 2026 | |
| RPRX Royalty Pharma | Rated: Buy | $67 → $75 | $69.45 | +7.99% | 32 | Nov 5, 2026 | |
| UTHR United Therapeutics | Rated: Hold | $566 → $568 | $588.61 | -3.50% | 36 | Nov 5, 2026 | |
| AMGN Amgen | Reiterated: Hold | $359 → $410 | $465.23 | -11.87% | 59 | Nov 4, 2026 | |
| PFE Pfizer | Reiterated: Hold | $28 → $26 | $29.36 | -11.44% | 62 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $19 → $21 | $15.11 | +38.98% | 20 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $665 → $660 | $547.89 | +20.46% | 57 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $310 → $346 | $293.89 | +17.73% | 57 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $779 → $855 | $916.06 | -6.67% | 62 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $41 → $40 | $62.80 | -36.31% | 54 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $163 → $183 | $170.87 | +7.10% | 66 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,430 → $1,596 | $1,432.29 | +11.43% | 82 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $177 → $174 | $148.05 | +17.53% | 60 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $231 → $238 | $253.25 | -6.02% | 63 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $294 → $292 | $280.78 | +4.00% | 60 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $15.88 | +139.29% | 19 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 → $29 | $6.40 | +353.13% | 11 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $126 | $21.73 | +479.84% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.90 | - | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $13.89 | -35.21% | 28 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $32 → $33 | $45.15 | -26.91% | 13 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.00 | n/a | 11 | Sep 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.51 | n/a | 6 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $16 | $46.47 | n/a | 13 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $12 | $1.98 | n/a | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €93.67 | €149.35 | n/a | 1 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $42.34 | $11.78 | n/a | 1 | Dec 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $16 | $88.81 | n/a | 2 | Mar 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $163 → $155 | $151.64 | n/a | 5 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $95.02 | n/a | 1 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $31 | $3.57 | n/a | 4 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 | $31.76 | n/a | 4 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $38 | $8.10 | n/a | 1 | Nov 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $36 | $1.56 | n/a | 1 | Jul 21, 2015 |
Legend Biotech
Nov 11, 2026
Maintained: Buy
Price Target: $48 → $43
Current: $20.41
Upside: +110.68%
BioNTech SE
Nov 9, 2026
Rated: Buy
Price Target: $106
Current: $87.21
Upside: +21.55%
Moderna
Nov 9, 2026
Rated: Hold
Price Target: $95
Current: $250.83
Upside: -62.13%
Arvinas
Nov 6, 2026
Rated: Hold
Price Target: $10
Current: $6.92
Upside: +44.51%
Intellia Therapeutics
Nov 6, 2026
Reiterated: Hold
Price Target: $15
Current: $11.17
Upside: +34.29%
Arcus Biosciences
Nov 6, 2026
Rated: Hold
Price Target: $23
Current: $18.67
Upside: +23.19%
Royalty Pharma
Nov 5, 2026
Rated: Buy
Price Target: $67 → $75
Current: $69.45
Upside: +7.99%
United Therapeutics
Nov 5, 2026
Rated: Hold
Price Target: $566 → $568
Current: $588.61
Upside: -3.50%
Amgen
Nov 4, 2026
Reiterated: Hold
Price Target: $359 → $410
Current: $465.23
Upside: -11.87%
Pfizer
Nov 4, 2026
Reiterated: Hold
Price Target: $28 → $26
Current: $29.36
Upside: -11.44%
Nov 3, 2026
Rated: Buy
Price Target: $19 → $21
Current: $15.11
Upside: +38.98%
Nov 3, 2026
Rated: Buy
Price Target: $665 → $660
Current: $547.89
Upside: +20.46%
Nov 2, 2026
Rated: Buy
Price Target: $310 → $346
Current: $293.89
Upside: +17.73%
Nov 2, 2026
Rated: Hold
Price Target: $779 → $855
Current: $916.06
Upside: -6.67%
Oct 30, 2026
Reiterated: Sell
Price Target: $41 → $40
Current: $62.80
Upside: -36.31%
Oct 30, 2026
Rated: Buy
Price Target: $163 → $183
Current: $170.87
Upside: +7.10%
Oct 30, 2026
Reiterated: Buy
Price Target: $1,430 → $1,596
Current: $1,432.29
Upside: +11.43%
Oct 30, 2026
Rated: Buy
Price Target: $177 → $174
Current: $148.05
Upside: +17.53%
Oct 29, 2026
Reiterated: Hold
Price Target: $231 → $238
Current: $253.25
Upside: -6.02%
Oct 15, 2026
Reiterated: Buy
Price Target: $294 → $292
Current: $280.78
Upside: +4.00%
Oct 15, 2026
Reiterated: Buy
Price Target: $38
Current: $15.88
Upside: +139.29%
Sep 2, 2026
Reiterated: Buy
Price Target: $39 → $29
Current: $6.40
Upside: +353.13%
Aug 10, 2026
Rated: Buy
Price Target: $126
Current: $21.73
Upside: +479.84%
Aug 10, 2026
Rated: Hold
Price Target: n/a
Current: $3.90
Upside: -
Apr 10, 2026
Reiterated: Hold
Price Target: $9
Current: $13.89
Upside: -35.21%
Feb 17, 2026
Reiterated: Sell
Price Target: $32 → $33
Current: $45.15
Upside: -26.91%
Sep 21, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.00
Upside: n/a
Dec 13, 2024
Reiterated: Hold
Price Target: n/a
Current: $2.51
Upside: n/a
Jun 1, 2021
Reiterated: Sell
Price Target: $16
Current: $46.47
Upside: n/a
Aug 10, 2020
Reiterated: Hold
Price Target: $21 → $12
Current: $1.98
Upside: n/a
Aug 3, 2020
Upgraded: Buy
Price Target: €93.67
Current: €149.35
Upside: n/a
Dec 2, 2019
Initiated Coverage: Hold
Price Target: $42.34
Current: $11.78
Upside: n/a
Mar 25, 2019
Downgraded: Hold
Price Target: $18 → $16
Current: $88.81
Upside: n/a
Aug 13, 2018
Reiterated: Buy
Price Target: $163 → $155
Current: $151.64
Upside: n/a
Jun 18, 2018
Initiated Coverage: Hold
Price Target: $22
Current: $95.02
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $32 → $31
Current: $3.57
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $46
Current: $31.76
Upside: n/a
Nov 18, 2015
Rated: Hold
Price Target: $38
Current: $8.10
Upside: n/a
Jul 21, 2015
Initiated Coverage: Hold
Price Target: $36
Current: $1.56
Upside: n/a